Reducing the Global Burden of Cardiovascular Disease, Part 1: The Epidemiology and Risk Factors.

@article{Joseph2017ReducingTG,
  title={Reducing the Global Burden of Cardiovascular Disease, Part 1: The Epidemiology and Risk Factors.},
  author={Philip G. Joseph and Darryl P. Leong and Martin Mckee and Sonia S Anand and J D Schwalm and Koon K Teo and Andrew Mente and Salim Yusuf},
  journal={Circulation research},
  year={2017},
  volume={121 6},
  pages={
          677-694
        }
}
Current global health policy goals include a 25% reduction in premature mortality from noncommunicable diseases by 2025. In this 2-part review, we provide an overview of the current epidemiological data on cardiovascular diseases (CVD), its risk factors, and describe strategies aimed at reducing its burden. In part 1, we examine the global epidemiology of cardiac conditions that have the greatest impact on CVD mortality; the predominant risk factors; and the impact of upstream, societal health… 
Cardiovascular disease in Mexico 1990–2017: secondary data analysis from the global burden of disease study
TLDR
The CVD burden of disease decreased between 1990 and 2017 in Mexico as a whole and in all states, with the higher decrease located in the north and central regions.
Mediterranean Diet and Cardiovascular Disease Prevention: What Do We Know?
TLDR
The MedDiet is one of the best dietary patterns analyzed in relation to CVD risk and other health outcomes, albeit a moderate-high degree of inconsistency has been reported and few studies have been included in most of the meta-analyses.
Epidemiology of cardiovascular disease and its risk factors in Korea.
  • H. Kim
  • Medicine
    Global health & medicine
  • 2021
TLDR
Based on the National Health Insurance claim database, the numbers of hospitalization for cerebrovascular disease and ischemic heart disease are increasing, but the age-standardized hospitalization rates are decreasing; unlike other types of CVDs, heart failure is rapidly increasing in both mortality andospitalization rates regardless of age- standardization.
Risk Assessment in CVD
TLDR
It is currently not clear whether assessment of the total CVD risk per se may help to reduce CVD events, but recommendations for preventive measures in subjects without existing CVD are based on the individual’s risk level.
Exercise Effects On Cardiovascular Disease: From Basic Aspects To Clinical Evidence.
TLDR
The exercise effects on many areas related to CVD are discussed, from basic aspects to clinical practice, in this state-of-the-art review.
Risk factors associated with cardiovascular diseases in Turkey: Evidence from National Health Survey
TLDR
While socio-economic inequalities, baseline illnesses, and smoking are related with higher risk of CVDs, regular exercise, physical activity and moderate alcohol consumption are found to be related with lower risk ofCVDs.
Global, Regional, and National Death, and Disability-Adjusted Life-Years (DALYs) for Cardiovascular Disease in 2017 and Trends and Risk Analysis From 1990 to 2017 Using the Global Burden of Disease Study and Implications for Prevention
TLDR
Although the mortality rate for CVD has declined in recent years from a global perspective, the results in 2017 suggest that the mortality and DALYs of CVD varied in different ages, sexes, and countries/regions around the world.
Hospital burden of coronary artery disease: Trends of myocardial infarction and/or percutaneous coronary interventions in France 2009–2014
TLDR
The public health burden of CAD and the importance of improving the trajectories of care as an aid for better care are outlined and the highest adjusted mortality rates were observed for inpatients aged <40 or >80.
Unhealthy Lifestyle, Genetics and Risk of Cardiovascular Disease and Mortality in 76,958 Individuals from the UK Biobank Cohort Study
TLDR
Unfavourable lifestyle behaviours predicted higher risk of all-cause mortality, CVD mortality, MI and stroke, independent of genetic risk.
Epidemiology and the Magnitude of Coronary Artery Disease and Acute Coronary Syndrome: A Narrative Review
TLDR
Examination of epidemiological data of coronary artery disease and acute coronary syndrome in low, middle and high income countries reveals the absolute global and regional trends of the CAD and the importance and contribution of CAD for global health.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 128 REFERENCES
Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015
TLDR
The GBD (Global Burden of Disease) 2015 study integrated data on disease incidence, prevalence, and mortality to produce consistent, up-to-date estimates for cardiovascular burden, finding that CVDs remain a major cause of health loss for all regions of the world.
Demographic and epidemiologic drivers of global cardiovascular mortality.
TLDR
The aging and growth of the population resulted in an increase in global cardiovascular deaths between 1990 and 2013, despite a decrease in age-specific death rates in most regions.
Estimating Deaths From Cardiovascular Disease: A Review of Global Methodologies of Mortality Measurement
TLDR
How mortality statistics are currently collected in both developed and developing countries, the various limitations of data, and how best to assess CVD-associated mortality in settings where most people die at home without death certificates or prior health records are reviewed are elucidated.
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study
TLDR
Abnormal lipids, smoking, hypertension, diabetes, abdominal obesity, psychosocial factors, consumption of fruits, vegetables, and alcohol, and regular physical activity account for most of the risk of myocardial infarction worldwide in both sexes and at all ages in all regions.
Cardiovascular risk and events in 17 low-, middle-, and high-income countries.
TLDR
Although the risk-factor burden was lowest in low-income countries, the rates of major cardiovascular disease and death were substantially higher inLow- Income countries than in high- income countries, which may have been mitigated by better control of risk factors.
Epidemiology of heart failure in Asia.
  • Y. Sakata, H. Shimokawa
  • Medicine
    Circulation journal : official journal of the Japanese Circulation Society
  • 2013
TLDR
It is needed to assemble and comprehensively analyze the available evidence to date for daily HF practice in Asia and to systematically conduct future epidemiologic approaches to establishing appropriate prevention programs against the burden of HF in Asia.
Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease.
TLDR
Treatment with rosuvastatin at a dose of 10 mg per day resulted in a significantly lower risk of cardiovascular events than placebo in an intermediate-risk, ethnically diverse population without cardiovascular disease.
Assessing the Global Burden of Ischemic Heart Disease: Part 1: Methods for a Systematic Review of the Global Epidemiology of Ischemic Heart Disease in 1990 and 2010.
TLDR
A systematic review of I HD epidemiology literature from 1980 to 2008 provided IHD epidemiology estimates for most world regions, but highlighted the lack of information about IHD in Sub-Saharan Africa and other low-income regions.
Low sodium intake--cardiovascular health benefit or risk?
  • S. Oparil
  • Medicine
    The New England journal of medicine
  • 2014
TLDR
Reducing dietary sodium and, to a lesser extent, increasing dietary potassium have been included in many guidelines for the treatment of hypertension and have been recommended in population-wide approaches to reducing blood pressure and therefore the burden of cardiovascular disease.
The Prospective Urban Rural Epidemiology (PURE) study: examining the impact of societal influences on chronic noncommunicable diseases in low-, middle-, and high-income countries.
TLDR
The PURE study builds on the work and experience gained through conduct of the INTERHEART study, and is geared toward addressing major questions on causation and development of the underlying determinants of cardiovascular disease in populations at varying stages of epidemiologic transition.
...
1
2
3
4
5
...